Application note: GMP Proteins for Therapeutic Manufacturing
Posted: 13 December 2019 | Bio-Techne | No comments yet
Immune cell therapies, stem cell therapies, and regenerative medicine, often grouped into the category of advanced therapy medicinal products (ATMPs), offer some of the most revolutionary and exciting new approaches for treating human disease.
Because they utilize living cells or tissues as the therapeutic, the manufacturing process is vastly more complex than those of more traditional treatment methods. The use of high-quality media supplements such as growth factors and cytokines is paramount to ensuring safety, efficacy, and minimizing batch-to-batch variability.
R&D Systems has a rich history of producing the most widely used proteins in the world. Our expertise in protein development and manufacturing, combined with stringent quality control and experienced regulatory support, allows us to offer industry-leading GMP proteins for cell therapy manufacturing.
Related content from this organisation
Related topics
cytokines, Stem Cells, Therapeutics
Related organisations
Bio-Techne